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Intracerebral hemorrhage location and
outcome among INTERACT2participants
ABSTRACT
Objective: To clarify associations between intracerebral hemorrhage (ICH) location and clinical
outcomes among participants of the main phase Intensive Blood Pressure Reduction in Acute
Cerebral Hemorrhage Trial (INTERACT2).
Methods: Associations between ICH sites and poor outcomes (death [6] or major disability [3–5] of
modified Rankin Scale) and European Quality of Life Scale (EQ-5D) utility scores at 90 days were
assessed in logistic regression models.
Results: Of 2,066 patients included in the analyses, associations were identified between ICH
sites and poor outcomes: involvement of posterior limb of internal capsule increased risks of
death or major disability (odds ratio [OR] 2.10) and disability (OR 1.81); thalamic involvement
increased risks of death or major disability (OR 2.24) and death (OR 1.97). Involvement of the pos-
terior limb of the internal capsule, thalamus, and infratentorial sites were each associated with
poor EQ-5D utility score (#0.7 [median]; OR 1.87, 2.14, and 2.81, respectively). Posterior limb
of internal capsule involvement was strongly associated with low scores across all health-related
quality of life domains. ICH encompassing the thalamus and posterior limb of internal capsule
were associated with death or major disability, major disability, and poor EQ-5D utility score (OR
1.72, 2.26, and 1.71, respectively).
Conclusion: Poor clinical outcomes are related to ICH affecting the posterior limb of internal
capsule, thalamus, and infratentorial sites. The highest association with death or major disability
and poor EQ-5D utility score was seen in ICH encompassing the thalamus and posterior limb of
internal capsule.
ClinicalTrials.gov registration: NCT00716079. Neurology® 2017;88:1–7
GLOSSARY
BP 5 blood pressure; CI 5 confidence interval; EQ-5D 5 European Quality of Life Scale; HRQoL 5 health-related quality of
life; ICH5 intracerebral hemorrhage; IQR5 interquartile range; IVH5 intraventricular hemorrhage; INTERACT25 Intensive
Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial; mRS 5 modified Rankin Scale; NIHSS 5 NIH Stroke Scale;
OR 5 odds ratio.
The prognosis for recovery from acute intracerebral hemorrhage (ICH) is strongly related to sev-
eral radiologic criteria. These include hematoma volume and the degree of extension of blood
into the ventricles and the subarachnoid space.1–3 Infratentorial location of ICH also predicts
a higher likelihood of death or dependency.1,4 However, the relationship between specific
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locations of supratentorial ICH and outcome
is poorly understood due in part to varying
designs and definitions across studies.5 We
examined associations of ICH location with
clinical outcomes among participants of the
main phase Intensive Blood Pressure Reduc-
tion in Acute Cerebral Hemorrhage Trial
(INTERACT2).6
METHODS Patients. The INTERACT2 study was a random-
ized, open, multicenter, controlled trial with blinded outcome
assessment conducted between 2008 and 2012.6 A total of
2,839 patients with imaging-confirmed ICH were randomly
assigned to receive either early intensive blood pressure (BP)–
lowering treatment (,140 mm Hg systolic BP goal) or the
contemporaneous guideline-recommended BP management
(,180 mm Hg systolic BP goal) within 6 hours of onset.
Follow-up was to 90 days.
Standard protocol approvals, registrations, and patient
consents. The study protocol was approved by the appropriate
ethics committee at each participating site, and written informed con-
sent was obtained from patients or appropriate surrogates. INTER-
ACT2 is registered with ClinicalTrials.gov (NCT00716079).
Measures. Demographic and clinical characteristics were re-
corded upon patient enrollment. CT scans were performed ac-
cording to standardized techniques (recommended slice
thickness: 5–8 mm) at baseline and centrally analyzed for volume
and location of ICH and the presence of intraventricular hemor-
rhage (IVH) extension.
Three neurologists reviewed all CT scans for detailed assess-
ment of sites involved by each ICH. Defined sites were the cau-
date head, putamen/globus pallidus, thalamus, posterior limb of
internal capsule, anterior limb of internal capsule, external cap-
sule, any lobar region, and infratentorial. ICH could involve
one or several sites. For small bleeds confined to any site, that site
was classified as involved. For 3 well-delimited sites (caudate
head, putamen/globus pallidus, and thalamus), involvement
was defined as replacement of over one-third of the structure
by blood (judgment made by assessor on CT scan axial slices).
For the remaining sites, posterior limb of internal capsule, ante-
rior limb of internal capsule, external capsule, any lobar location,
and infratentorial any involvement led to these sites being classi-
fied as affected. Superficial supratentorial or lobar location was
selected when structures other than deep structures (caudate, pu-
tamen/globus pallidus, thalamus, internal capsule) were involved.
In large volume ICH, where the hemorrhage spanned the hemi-
sphere from the ventricle to the cortex, location was rated as both
deep, with affected sites listed, and lobar. ICH were then evalu-
ated for their entire location, which could involve single or mul-
tiple sites. The term encompassing has been used to describe
common patterns of ICH that involve one or more of the sites
defined above.
Outcomes for these analyses were death or major disability as
assessed by the modified Rankin Scale (mRS) (death, score of 6;
major disability, score of 3–5) and health-related quality of life
(HRQoL) as self-assessed by the patient or by a proxy responder
using the European Quality of Life Scale (EQ-5D)7 questionnaire
at 90 days. The EQ-5D uses a descriptive system defining the
state of general health across 5 dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression), with
respondents rating their assessment of each as having no (score
of 1), some or moderate (score of 2), or severe problems (score of
3). A utility score integrating ratings of the 5 dimensions into
a single score was calculated by using population-based preference
weights obtained from the UK population for each subscale. The
utility score expresses HRQoL quantitatively as a fraction of
perfect health: a score of 1 represents perfect health, 0 represents
death, and negative scores represent health states considered
worse than death; a score between 0.8 and 0.9 represents the
average score in the general population.8–10 Both measures were
used in the present analysis.
Statistical analysis. Baseline characteristics of included and
excluded patients were summarized by means and SD for normally
distributed variables, medians and interquartile ranges (IQR) for
skewed continuous variables, and numbers (%) for categorical var-
iables. Between-group differences were assessed using the x2 test for
categorical variables and theWilcoxon test for continuous variables.
Associations between ICH sites of involvement and death or major
disability, poor HRQoL in each domain (grades of some to
moderate or severe vs no problems in the corresponding
dimensions), and poor overall HRQoL (utility score #0.7
[dichotomized by median]) were assessed in multivariable logistic
regression models, adjusted for potential confounders. The adjusted
variables included age, female sex, China region of recruitment,
history of ischemic stroke and diabetes mellitus, medication
history of antihypertensives, antithrombotics, and lipid-lowering
agents, NIH Stroke Scale (NIHSS) score ($11 vs ,11
[dichotomized by median]), systolic BP, onset to CT time (log-
transformed), baseline hematoma volume (log-transformed), IVH,
allocation to intensive BP lowering, laterality (left vs right), and
proxy response for the HRQoL models. Each individual site
(caudate head, putamen/globus pallidus, thalamus, external
capsule, anterior limb of internal capsule, posterior limb of
internal capsule, lobar, and infratentorial) was included in the
multivariable model to identify independent relationships
between specific sites and outcome. The same analysis was
repeated without adjusting for NIHSS. Also, common patterns
of entire ICH encompassing one or multiple sites were included
in a multivariable model adjusted for the same variables except
individual sites. A standard level of significance (p , 0.05) was
used and the data are reported with odds ratios (OR) and 95%
confidence intervals (CI). All analyses were performed using SAS
software version 9.3 (SAS Institute, Cary, NC).
RESULTS Among the 2,829 INTERACT2 partici-
pants, 2,066 (73%) were included in the mortality
and functional outcome analyses with available base-
line DICOM format CT and information on outcome
(mRS) at 90 days (figure e-1 at Neurology.org).
Table 1 shows the baseline characteristics of included
and excluded patients; the former had smaller ICH
(median 10.7 [IQR 5.6–18.7] mL vs 12.0 [6.3–23.
9] mL) and were more likely to answer the EQ-5D
questions themselves (fewer proxy responders,
indicative of less severe ICH).
Table e-1 shows the most common patterns of
ICH. Entire ICH included 56 combinations of possi-
ble sites. Of these possible combinations, 42 (75%)
were present in fewer than 10 patients, 6 (11%) in
between 10 and 50 patients, and 8 (14%) in more than
130 patients (total n 5 1,747, 85% of the total pop-
ulation). The most common patterns were putamen/
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globus pallidus alone (n 5 342), thalamus and poste-
rior limb of internal capsule (n5 339), posterior limb
of internal capsule, putamen/globus pallidus, and
external capsule (n 5 236), thalamus alone (n 5
181), lobar alone (n5 181), putamen/globus pallidus
and posterior limb of internal capsule (n 5 177),
putamen/globus pallidus and external capsule (n 5
153), and infratentorial alone (n 5 138).
Table 2 shows associations between ICH sites of
involvement and death or major disability at 90 days.
In models adjusted for baseline differences, thalamic,
lobar, and infratentorial involvement were associated
with death: OR 1.97 (95% CI 1.18–3.29), 1.95
(1.21–3.15), and 2.45 (1.09–5.50), respectively.
ICH involving the posterior limb of internal capsule
was associated with major disability: OR 1.81 (95%
CI 1.45–2.26). ICH involving the thalamus, poste-
rior limb of internal capsule, and infratentorial was
associated with the composite endpoint of death and
major disability: OR 2.24 (95% CI 1.40–3.57), 2.10
(1.65–2.68), and 3.04 (1.68–5.50), respectively. The
same model with all the included variables is shown
in table e-2.
For analysis of HRQoL, 251 patients who died
within 90 days and 36 without EQ-5D information
were excluded, leaving 1,779 patients for analysis of
HRQoL (figure e-1). Table 3 shows associations
between ICH location and HRQoL. After adjusting
for potential confounders, thalamic OR 2.14 (95%
CI 1.32–3.48), posterior limb of internal capsule OR
1.87 (95% CI 1.45–2.40), and infratentorial OR
2.81 (95% CI 1.52–5.20) sites were each associated
with poor overall HRQoL (utility score #0.7). Pos-
terior limb of internal capsule was associated with
poor HRQoL across all domains. Thalamic and in-
fratentorial sites were associated with poor HRQoL in
the mobility, self-care, and usual activity domains.
The same model with all the included variables is
shown in table e-3. Tables e-2 and e-3 show that
death, major disability, and poor HRQoL were also
associated with older age, increased baseline neuro-
logic severity (NIHSS), and baseline ICH volume.
Similar results were found when the analyses were
not adjusted for NIHSS (tables e-4 and e-5).
Table 4 shows associations between the most com-
mon patterns of entire ICH and death or disability at
90 days. After adjustment for potential confounders,
ICH encompassing the thalamus and posterior limb
of internal capsule were associated with death or
major disability (OR 1.72 [95% CI 1.14–2.58])
and major disability (2.26 [1.58–3.23]). ICH encom-
passing the posterior limb of internal capsule and
putamen/globus pallidus with or without additional
involvement of the external capsule were associated
with disability (OR 1.69 [95% CI 1.13–2.54] and
1.52 [1.04–2.21]).
Table 5 shows associations between the most com-
mon patterns of entire ICH and HRQoL. After
adjustment for potential confounders, ICH encom-
passing the thalamus and posterior limb of internal
capsule were associated with poor EQ-5D utility
score (#0.7 [median]; OR 1.71 [95% CI 1.12–
Table 1 Characteristics of Intensive Blood Pressure Reduction in Acute
Cerebral Hemorrhage Trial (INTERACT2) participants included in and
excluded from the analyses
Included
(n 5 2,066)
Excluded
(n 5 763)
p
Valuea
Demographics
Age, y, mean 6 SD 64 6 13 63 6 13 0.45
Female 772 (37) 277 (36) 0.60
China region 1,381 (67) 539 (71) 0.06
Medical history
Intracerebral hemorrhage 160 (8) 69 (9) 0.25
Ischemic stroke 211 (10) 75 (10) 0.78
Hypertension 1,489 (72) 559 (73) 0.48
Diabetes 230 (11) 75 (10) 0.33
Medication history
Antihypertensives 953 (46) 321 (42) 0.06
Antithrombotics 254 (12) 80 (11) 0.19
Lipid-lowering agents 151 (7) 51 (7) 0.58
Clinical features
Time from onset to CT, h, median (IQR) 1.8 (1.2–2.7) 1.8 (1.2–2.7) 0.36
Systolic BP, mm Hg, mean 6 SD 179 6 17 179 6 17 0.58
Diastolic BP, mm Hg, mean 6 SD 101 6 15 102 6 15 0.22
NIHSS score, median (IQR) 11 (6–16) 10 (6–15) 1.00
CT findings
Hematoma volume, mL, median (IQR) 10.7 (5.6–
18.7)
12.0 (6.3–
23.9)
0.001
Left hemisphere ICH 1,059 (51) 254 (46) 0.04
Involved locations
Caudate head 42 (2) 1 (4) 0.44
Thalamus 640 (31) 7 (30) 0.96
Putamen/globus pallidus 1,161 (56) 11 (48) 0.42
External capsule 553 (27) 5 (22) 0.59
Anterior limb of internal capsule 102 (5) 2 (9) 0.41
Posterior limb of internal capsule 957 (46) 8 (35) 0.27
Lobar 297 (14) 6 (26) 0.11
Infratentorial 141 (7) 2 (9) 0.72
Intraventricular extension 595 (29) 145 (27) 0.29
Randomized intensive BP lowering 1,031 (50) 368 (48) 0.43
Proxy responder at 90-day HRQoL assessment 728 (40) 227 (48) 0.002
Abbreviations: BP 5 blood pressure; HRQoL 5 health-related quality of life; IQR 5 inter-
quartile range; NIHSS 5 NIH Stroke Scale.
Data are n (%) unless stated otherwise.
ap Value x2 test for categorical variables and Wilcoxon test for continuous variables.
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2.60]) and poor HRQoL in the self-care, usual activ-
ity, and pain/discomfort domains: OR 2.08 (95% CI
1.34–3.22), 2.26 (1.42–3.60), and 1.78 (1.21–2.62),
respectively. Thalamic ICH was associated with poor
HRQoL in the usual activity and pain/discomfort
domains: OR 1.75 (95% CI 1.04–2.95) and 1.58
(1.00–2.49; p5 0.049). Infratentorial ICH was asso-
ciated with poor HRQoL in the mobility and usual
Table 2 Multivariable logistic regression analyses for associations between ICH sites of involvement and
outcome
No.
Death or major
disability Major disability Death
OR 95% CI OR 95% CI OR 95% CI
Caudate head 42 0.42 0.16–1.14 0.24 0.09–0.62a 2.19 0.77–6.26
Thalamus 640 2.24 1.40–3.57b 1.18 0.82–1.71 1.97 1.18–3.29a
Putamen/globus pallidus 1,161 1.36 0.87–2.14 0.86 0.60–1.22 1.11 0.68–1.82
External capsule 553 1.05 0.78–1.40 0.96 0.74–1.25 1.23 0.81–1.87
Anterior limb of internal capsule 102 1.03 0.56–1.91 1.00 0.59–1.71 0.94 0.45–1.97
Posterior limb of internal capsule 957 2.10 1.65–2.68b 1.81 1.45–2.26b 1.04 0.72–1.51
Lobar 297 1.34 0.86–2.08 0.61 0.43–0.88a 1.95 1.21–3.15a
Infratentorial 141 3.04 1.68–5.50b 1.27 0.77–2.11 2.45 1.09–5.50c
Abbreviations: CI 5 confidence interval; ICH 5 intracerebral hemorrhage; No. 5 number of cases by ICH location; OR 5
odds ratio.
Multivariable models were adjusted for age, female sex, China region, history of ischemic stroke and diabetes, medication
history of antihypertensives, antithrombotics, and lipid-lowering agents, NIH Stroke Scale score ($11 vs ,11), systolic
blood pressure, onset to CT time (log-transformed), baseline hematoma volume (log-transformed), caudate head, thalamus,
putamen/globus pallidus, external capsule, anterior and posterior limbs of internal capsule, lobar, infratentorial, and intra-
ventricular extension of hematoma, ICH laterality, and randomization to intensive blood pressure–lowering. The c statistics
for the models of death or major disability, major disability, and death were 0.83, 0.72, and 0.82, respectively.
a 0.001 # p , 0.01.
bp , 0.001.
c 0.01 # p # 0.05.
Table 3 Multivariable logistic regression analyses for associations between ICH sites of involvement and health-related quality of life
measured by the 5-dimension European Quality of Life scale, by utility score (£0.7 vs>0.7) and dimension (some/moderate or severe
problems vs no problem)
No.
Utility score Mobility Self-care Usual activity Pain/discomfort
Anxiety/
depression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Caudate head 42 0.26 0.08–0.82a 1.59 0.57–4.47 0.28 0.09–0.89a 0.32 0.10–1.00 0.60 0.23–1.60 0.24 0.07–0.83a
Thalamus 640 2.14 1.32–3.48b 2.42 1.45–4.05c 2.28 1.37–3.82b 3.00 1.69–5.31c 0.90 0.60–1.35 1.31 0.86–1.99
Putamen/globus pallidus 1,161 1.27 0.80–2.02 1.34 0.81–2.20 1.24 0.76–2.02 1.59 0.92–2.76 0.82 0.55–1.21 0.98 0.66–1.48
External capsule 553 0.98 0.73–1.33 1.16 0.86–1.57 1.19 0.87–1.62 1.17 0.85–1.61 0.86 0.65–1.13 0.75 0.56–1.00
Anterior limb of internal
capsule
102 1.33 0.70–2.53 0.72 0.38–1.35 1.12 0.58–2.18 0.79 0.40–1.55 1.11 0.63–1.95 1.50 0.83–2.72
Posterior limb of internal
capsule
957 1.87 1.45–2.40c 1.54 1.19–1.99b 2.04 1.57–2.65c 1.70 1.30–2.23c 1.51 1.19–1.90c 1.41 1.11–1.80b
Lobar 297 1.18 0.74–1.87 1.23 0.74–2.03 1.08 0.66–1.76 1.51 0.88–2.62 0.71 0.47–1.08 1.03 0.67–1.57
Infratentorial 141 2.81 1.52–5.20b 4.03 2.16–7.50c 2.57 1.35–4.87b 3.66 1.88–7.15c 1.11 0.66–1.89 1.35 0.77–2.38
Abbreviations: CI 5 confidence interval; ICH 5 intracerebral hemorrhage; No. 5 number of cases by ICH location; OR 5 odds ratio.
Multivariable models were adjusted for age, female sex, China region, history of ischemic stroke and diabetes, medication history of antihypertensives,
antithrombotics, and lipid-lowering agents, NIH Stroke Scale score ($11 vs ,11), systolic blood pressure, onset to CT time (log-transformed), baseline
hematoma volume (log-transformed), caudate head, thalamus, putamen/globus pallidus, external capsule, anterior and posterior limbs of internal capsule,
lobar, infratentorial, and intraventricular extension of hematoma, ICH laterality, randomization to intensive blood pressure–lowering management policy,
and proxy responders. The c statistics for the models of utility score, mobility, self-care, usual activity, pain/discomfort, and anxiety/depression were 0.79,
0.78, 0.83, 0.82, 0.66, and 0.69, respectively.
a 0.01 # p # 0.05.
b0.001 # p , 0.01.
cp , 0.001.
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activity domain: OR 1.78 (95% CI 1.02–3.10) and
1.86 (1.06–3.26). ICH encompassing the putamen/
globus pallidus, posterior limb of internal capsule,
and external capsule were associated with poor
HRQoL in the pain/discomfort domain: OR 1.65
(95% CI 1.10–2.47).
Table e-6 shows the hematoma volume by site of
involvement and table e-7 shows the model fit statis-
tics for tables 2 and 3.
DISCUSSION This secondary analysis of the INTER-
ACT2 study dataset demonstrates strong associations
between the location of ICH and clinically relevant,
patient-centered outcomes. Any ICH that involves the
posterior limb of internal capsule or thalamus increases
the risks of death or disability and of disability alone.
ICH involving the posterior limb of the internal
capsule, thalamus, and infratentorial sites were each
associated with poor HRQoL. In particular,
involvement of the posterior limb of the internal
capsule was strongly associated with poor outcomes
across all HRQoL domains. Of the 8 common
recognizable patterns of ICH, the striking characteristic
is that all of these that involve the posterior limb of
internal capsule are associated with major disability.
Isolated thalamic hemorrhage and ICH encompassing
the thalamus and posterior limb of internal capsule are
associated with poor HRQoL. These data indicate that
damage to the capsular pyramidal tracts is particularly
disabling, while ICH involving the thalamus and
posterior fossa are more likely to be fatal. In contrast,
ICH confined to a lobar site seems to have a relatively
benign prognosis when adjusted for hemorrhage
volume. However, this does not necessarily mean that
outcome after a capsular ICH is worse than outcome
after a lobar ICH, as mean hemorrhage volume in
lobar ICH is large by comparison with deep ICH and
volume itself is an important predictor of outcome.1
When looking at ICH that involved a lobar site and
one or more other sites, there is an increased risk of
death. This is likely to reflect the fact that these are
extensive ICH spanning from deep structures to the
cortex. Finally, the analysis confirms well-recognized
associations between older age,11,12 higher neurologic
severity, ICH volume, and poor outcomes.1
There is increasing interest in the assessment of
HRQoL after stroke, but there has been limited data
on its association with ICH in specific brain loca-
tions. In the Factor VII for Acute Intracerebral
Hemorrhage trial, deep compared to lobar location
of ICH was associated with poor HRQoL,13 but
no further assessment of anatomical structures was
undertaken.
Damage to the posterior limb of the internal cap-
sule on diffusion tensor tractography has been shown
to be related to poor motor outcome and to disability
in the ischemic stroke literature,14 while ICH in the
thalamus has been shown to be associated with higher
in-hospital mortality compared to ICH in other
supratentorial locations.15 The pyramidal tracts pass
through the posterior limb of the internal capsule
location16 and pathology affecting motor function
has predictable consequences for disability and
HRQoL17 related directly to domains of mobility,
usual activity, and self-care, and indirectly to the
more subjective domains of pain/discomfort and anx-
iety/depression. Thalamic ICH is prone to leak blood
into the ventricles18 and may extend to compress the
brainstem with life-threatening consequences.
Greater residual neurologic deficit may explain why
survivors of ICH involving the posterior limb of
internal capsule, thalamus, and infratentorium had
worse overall HRQoL compared to those who recover
from ICH in other locations. The finding that the
domains of pain/discomfort and anxiety/depression
showed no significant associations with thalamic
involvement and a very weak association for the
former with thalamic ICH in the multivariable mod-
els is surprising. Strokes in the thalamus have a high
Table 4 Multivariable logistic regression analyses for associations between the
most common entire ICH encompassing one or multiple sites and
outcome
No.
Death or major
disability Major disability Death
OR 95% CI OR 95% CI OR 95% CI
Thalamus 181 1.02 0.64–1.63 1.32 0.86–2.01 1.21 0.65–2.24a
Putamen 342 0.44 0.29–0.65b 0.69 0.48–0.99a 0.50 0.28–0.90
Infratentorial 138 1.31 0.77–2.22 1.32 0.81–2.16 1.23 0.55–2.74
Lobar 181 0.44 0.27–0.71b 0.60 0.39–0.92a 0.67 0.39–1.17
Thalamus and
posterior limb of
internal capsule
339 1.72 1.14–2.58c 2.26 1.58–3.23b 0.71 0.42–1.22
Putamen/globus
pallidus and
posterior limb of
internal capsule
177 1.32 0.83–2.11 1.69 1.13–2.54a 0.66 0.35–1.24
Putamen/globus
pallidus and
external capsule
153 0.56 0.35–0.91 0.95 0.61–1.46 0.45 0.21–0.96a
Putamen/globus
pallidus, posterior
limb of internal
capsule and
external capsule
236 1.07 0.69–1.65 1.52 1.04–2.21a 0.57 0.33–1.01
Abbreviations: CI 5 confidence interval; ICH 5 intracerebral hemorrhage; OR 5 odds ratio.
Multivariable models were adjusted for age, female sex, China region, history of ischemic
stroke and diabetes, medication history of antihypertensives, antithrombotics, and lipid-
lowering agents, NIH Stroke Scale score ($11 vs ,11), systolic blood pressure, onset to CT
time (log-transformed), baseline hematoma volume (log-transformed), intraventricular
extension of ICH, ICH laterality, and randomization to intensive blood pressure–lowering
management policy. The c statistics for the models of death or major disability, major dis-
ability, and death were 0.82, 0.72, and 0.82, respectively.
a 0.01 # p # 0.05.
bp , 0.001.
c 0.001 # p , 0.01.
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incidence of residual sensory disability and are tradi-
tionally associated with pain syndromes,19 while le-
sions of spinothalamic afferents to the posterior
thalamus are associated with development of central
pain.20 This effect seems small in ICH.
Strengths of our analysis include the assessment of
HRQoL in a large group of participants with ICH
with rigorous and structured central adjudication of
images for determining ICH location. Limitations
include selection bias from a clinical trial population
where patients with severe ICH were purposefully
excluded. From a practical point of view, the excluded
patients were those with a very high likelihood of
early death, so they might be expected to influence
mortality calculations but not necessarily HRQoL
outcomes. Another issue is that ICH location was as-
sessed on varying thicknesses of axial slices of brain
CT scans, which adds some noise to the data but
probably not of sufficient magnitude to bias the
observed changes in one particular site over another.
There was a small number of infratentorial and lobar
ICH, not allowing for further anatomical segmenta-
tion of these compartments. Despite the large size
of the INTERACT dataset, when individual com-
plete hemorrhage is analyzed the numbers are reduced
to the point where less powerful effects no longer
reach significance. Again, this affects mortality analy-
sis more than disability for the reasons stated above.
We have shown that specific ICH sites, namely the
posterior limb of the internal capsule, thalamus, and
infratentorium, are associated with poor HRQoL in
survivors. Infratentorial and thalamic involvement by
ICH are associated with the greatest risk of death,
and internal capsule lesions with the greatest residual
disability. It is well-recognized that infratentorial loca-
tion is a poor prognostic factor. To this, we can now
add deep, posterior supratentorial locations involving
the thalamus or posterior limb of internal capsule.
These data offer additional practical help for clinicians
in assessing patients with ICH and counseling patients
and families, as well as in planning rehabilitation and
developing individualized pathways of care.
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Table 5 Multivariable logistic regression analyses for associations between themost common entire ICH (encompassing one or multiple sites)
and health-related quality of life measured by the 5-dimension European Quality of Life scale, by utility score (£0.7 vs >0.7) and
dimension (some/moderate or severe problems vs no problem)
No.
Utility score Mobility Self-care Usual activity Pain/discomfort Anxiety/depression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Thalamus 181 1.63 1.00–2.66 1.04 0.63–1.73 1.13 0.68–1.88 1.75 1.04–2.95a 1.58 1.00–2.49a 1.43 0.90–2.29
Putamen 342 0.53 0.35–0.81b 0.53 0.35–0.80b 0.49 0.32–0.75b 0.67 0.43–1.03 1.08 0.74–1.58 0.70 0.47–1.04
Infratentorial 138 1.55 0.89–2.69 1.78 1.02–3.10a 1.27 0.72–2.25 1.86 1.06–3.26a 1.57 0.94–2.60 1.17 0.68–2.01
Lobar 181 0.55 0.33–0.91a 0.44 0.26–0.74b 0.43 0.25–0.73a 0.63 0.37–1.08 0.97 0.61–1.54 0.77 0.48–1.23
Thalamus and posterior
limb of internal capsule
339 1.71 1.12–2.60a 1.55 0.99–2.43 2.08 1.34–3.22a 2.26 1.42–3.60c 1.78 1.21–2.62b 1.34 0.90–1.99
Putamen/globus
pallidus and posterior
limb of internal capsule
177 1.48 0.92–2.39 0.85 0.52–1.41 1.30 0.79–2.14 1.41 0.84–2.38 1.73 1.12–2.67a 1.60 1.03–2.49a
Putamen/globus
pallidus and external
capsule
153 0.45 0.27–0.75b 0.60 0.36–0.99a 0.63 0.38–1.05 0.76 0.45–1.29 0.68 0.42–1.09 0.56 0.34–0.93a
Putamen/globus
pallidus, posterior limb
of internal capsule and
external capsule
236 1.25 0.81–1.94 0.87 0.54–1.41 1.16 0.74–1.84 1.49 0.90–2.46 1.65 1.10–2.47a 0.83 0.55–1.26
Abbreviations: CI 5 confidence interval; ICH 5 intracerebral hemorrhage; No. 5 number of cases by intracerebral hemorrhage location; OR 5 odds ratio.
Multivariable models were adjusted for age, female sex, China region, history of ischemic stroke and diabetes, medication history of antihypertensives,
antithrombotics, and lipid-lowering agents, NIH Stroke Scale score ($11 vs ,11), systolic blood pressure, onset to CT time (log-transformed), baseline
hematoma volume (log-transformed), caudate head, thalamus, putamen/globus pallidus, external capsule, anterior and posterior limbs of internal capsule,
lobar, infratentorial, and intraventricular extension of hematoma, ICH laterality, randomization to intensive blood pressure–lowering management policy,
and proxy responders. The c statistics for the models of utility score, mobility, self-care, usual activity, pain/discomfort, and anxiety/depression were 0.79,
0.78, 0.82, 0.82, 0.66, and 0.69, respectively.
a 0.01 # p # 0.05.
b0.001 # p , 0.01.
cp , 0.001.
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